Beijing Tongrentang Co., Ltd (SHA:600085)
23.89
-0.59 (-2.41%)
Aug 31, 2026, 3:00 PM CST
Beijing Tongrentang Revenue
Beijing Tongrentang had revenue of 3.72B CNY in the quarter ending June 30, 2026, a decrease of -17.32%. This brings the company's revenue in the last twelve months to 15.87B, down -14.71% year-over-year. In the year 2025, Beijing Tongrentang had annual revenue of 17.26B, down -7.21%.
Revenue (ttm)
15.87B
Revenue Growth
-14.71%
P/S Ratio
2.12
Revenue / Employee
917.98K
Employees
17,284
Market Cap
33.57B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.26B | -1.34B | -7.21% |
| Dec 31, 2024 | 18.60B | 736.39M | 4.12% |
| Dec 31, 2023 | 17.86B | 2.49B | 16.19% |
| Dec 31, 2022 | 15.37B | 769.32M | 5.27% |
| Dec 31, 2021 | 14.60B | 1.78B | 13.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 44.00B |
| China Resources Sanjiu Medical & Pharmaceutical | 31.81B |
| Humanwell Healthcare (Group) | 23.96B |
| Changchun High-Tech Industry (Group) | 11.02B |
| Apeloa Pharmaceutical Co.,Ltd | 9.16B |
| Zhejiang Huahai Pharmaceutical | 8.98B |
| Shijiazhuang Yiling Pharmaceutical | 7.87B |
| Dong-E-E-Jiao | 6.80B |
Beijing Tongrentang News
- 2 months ago - Beijing Tongrentang (TONG) Plans to Raise Up to HK$671.6 Million in IPO - GuruFocus
- 4 months ago - Beijing Tongrentang Quarterly report: Q1 2026 - Filings
- 5 months ago - Beijing Tongrentang Annual report: H2 2025 - Filings
- 10 months ago - Beijing Tongrentang Quarterly report: Q3 2025 - Filings
- 1 year ago - Beijing Tongrentang Quarterly report: H1 2025 - Filings